These alterations in response to smoking appear to have a wide-ranging negative influence on the immune system, and a strong involvement in processes related to cancer, cell death and metabolism.
The scientists indentified 323 unique genes whose expression levels were significantly correlated with smoking behavior in their study of 1,240 people. The changes were detected by studying the activity of genes within white blood cells of study participants.
“Our results indicate that not only individual genes but entire networks of gene interaction are influenced by cigarette smoking,” wrote lead author Jac Charlesworth, Ph.D., in the July 15 issue of the open access journal BMC Medical Genomics. Charlesworth, formerly at SFBR, is now a research fellow at the Menzies Research Institute at the University of Tasmania in Australia.
The study was funded by the National Institutes of Health and the Azar and Shepperd families of San Antonio, ChemGenex Pharmaceuticals and the AT&T Foundation. The study is part of SFBR’s San Antonio Family Heart Study (SAFHS) which includes 40 families in the Mexican American community.
“Previous studies of gene expression as influenced by smoking have been seriously limited in size with the largest of the in vivo studies including only 42 smokers and 43 non-smokers. We studied 1,240 individuals, including 297 current smokers” Charlesworth said. “Never before has such a clear link between smoking and transcriptomics been revealed, and the scale at which exposure to cigarette smoke appears to influence the expression levels of our genes is sobering”.
“Our results indicate that not only individual genes but entire networks of gene interaction are influenced by cigarette smoking. It is likely that this observed effect of smoking on transcription has larger implications for human disease risk, especially in relation to the increased risk of a wide variety of cancers throughout the body as a result of cigarette smoke exposure,” Charlesworth said.
All of Charlesworth’s ten co-authors on this paper are doctoral level faculty and staff in SFBR’s Department of Genetics and members of the group of investigators working on the SAFHS lead by Principal Investigator John Blangero, Ph.D.
Charlesworth can be reached in Australia after 6 pm CT at 613-6226 -4607, or at [email protected] Co-authors, Joanne E. Curran, Ph.D., or Michael Mahaney, Ph.D., of SFBR are also available for interviews. They can be reached through Joe Carey, SFBR’s Vice President for Public Affairs at 210-258-9437.
SFBR is one of the world’s leading independent biomedical research institutions dedicated to advancing health worldwide through innovative biomedical research. Located on a 200-acre campus on the northwest side of San Antonio, Texas, SFBR partners with hundreds of researchers and institutions around the world, targeting advances in the fight against cardiovascular disease, diabetes, obesity, cancer, psychiatric disorders, problems of pregnancy, AIDS, hepatitis, malaria, parasitic infections and a host of other infectious diseases. For more information on SFBR, go to www.sfbr.org.